Par Drugs & Chemicals Reports Q2 FY27 Financial Results
Par Drugs and Chemicals Ltd 路 Outcome 路 29 Oct 2026, 10:35 pm
Par Drugs & Chemicals Reports Q2 FY27 Financial Results Par Drugs and Chemicals approved its standalone financial results for the quarter ended 30th Sep'26. Revenue from operations reached Rs 2,743.19 lakhs, down 12.30% QoQ from Rs 3,128.05 lakhs in Jun'26 and 4.28% YoY from Rs 2,865.89 lakhs in Sep'25. Net profit dropped 44.23% QoQ and 36.36% YoY to Rs 262.80 lakhs, yielding an EPS of Rs 2.14 compared to Rs 3.83 in Jun'26 and Rs 3.36 in Sep'25. For H1 ended 30th Sep'26, revenue stood at Rs 5,871.24 lakhs with net profit of Rs 734.07 lakhs.
Original exchange filing (PDF)
More announcements from Par Drugs and Chemicals Ltd
- Par Drugs And Chemicals Limited has informed the Exchange regarding 'Outcome of Board Meeting dated 29.10.2026'. 路 29 Oct 2026
- Par Drugs And Chemicals Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. 路 29 Oct 2026
- PAR DRUGS AND CHEMICALS LIMITED has informed the Exchange about Board Meeting to be held on 29-Oct-2026 to consider and approve the Half Yearly Unaudited Financial results of the Company for the period ended September 2026 and Other business. 路 29 Oct 2026
- To consider and approve the financial results for the period ended September 30, 2026 and other business matters 路 29 Oct 2026
- Par Drugs And Chemicals Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on September 26, 2026. Further, the company has informed the Exchange regarding voting results. 路 27 Sept 2026
- Par Drugs And Chemicals Limited has informed the Exchange regarding 'Proceeding of AGM dated 26.09.2026'. 路 26 Sept 2026
- Par Drugs And Chemicals Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on September 26, 2026 路 26 Sept 2026
- Par Drugs And Chemicals Limited has informed the Exchange regarding 'Regulation 36 (1)(b)'. 路 01 Sept 2026
